SecondWave Systems, Inc.

SecondWave Systems, Inc. is a clinical-stage medical technology company focused on developing a noninvasive, wearable ultrasound stimulation platform. Their flagship product is a low-intensity focused ultrasound device that modulates nerves, cells, and organs to stimulate physiological responses, particularly targeting inflammation and immune modulation. This innovative approach aims to provide new treatment options for chronic inflammatory diseases such as rheumatoid arthritis and complex conditions like Long COVID. Founded by Anuj Bhardwaj, Jeff Heyman, and Hubert Lim, the company leverages expertise in ultrasonic technology to pioneer therapeutic applications in medicine. Their device is designed for in-home self-administration, allowing patients to manage their treatment conveniently while reducing the need for frequent clinical visits. With proprietary sensing and imaging capabilities, the platform delivers adaptive, personalized therapy that can complement or serve as an alternative to pharmaceutical treatments. SecondWave Systems is committed to expanding the boundaries of modern medicine by offering non-pharmacological therapeutic options for patients and healthcare providers.

• Employees 15
• Founded 2019
• Annual Revenue $3000000
• Total Funding $36000000